{
    "code": "02023401",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023401",
    "time": "2020-02-25 13:07:25",
    "許可證字號": "衛署藥輸字第023401號",
    "註銷狀態": "已註銷",
    "註銷日期": "97\/10\/27",
    "註銷理由": "未展延而逾期者",
    "有效日期": "96\/03\/25",
    "發證日期": "91\/03\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202340102",
    "中文品名": "妥妙得適凍晶注射劑２公絲",
    "英文品名": "TOMUDEX 2MG LYOPHILISED POWDER FOR I.V. INFUSION",
    "適應症": "限使用於晚期或轉移性結腸直腸癌，病患經5-FLUOROURACIL藥物治療，引起第四級嗜中性白血球缺乏缺(GRADE IV NEUTROPENIA)及嚴重性腹瀉(第四級者)",
    "劑型": "243凍晶注射劑",
    "包裝": "2公絲玻璃容器裝 100小瓶以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
        "申請商地址": "台北巿敦化南路二段２０７號２１樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FGB0053000  ASTRAZENECA UK LIMITED",
            "製造廠廠址": "SILK ROAD BUSINESS PARK,MACCLESFIELD,CHESHIRE,SK10 2NAALDERLEY PARK MACCLESFIELD CHESHIRE SK 10 4TF",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000800",
            "成分名稱": "RALTITREXED",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ]
}